EVIFX Fees and Costs — Eaton Vance Balanced Fund, Class A

Data updated: 2026-08-24

The net expense ratio is 0.96%. This share class carries a maximum front-end sales load of 5.25%. Portfolio turnover was 4%.

EVIFX Fees and Expenses

Annual operating expenses and sales charges of EVIFX. Prospectus, as of December 31, 2025.

Annual operating expenses
Management fee0.04%
12b-1 fee0.25%
Other expenses0.09%
Gross expense ratio0.96%
Fee waiver—
Net expense ratio0.96%
Sales charges
Max front load5.25%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

EVIFX Costs Over Time

On $10,000 invested in EVIFX, assuming 5% a year before costs, total costs come to $1,239 over 5 years, cutting the return by 2.12% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Sales charges$525$525$525
Fund expenses (net expense ratio 0.96%)$96$298$517
Lost growth on money paid in costs$26$98$197
Total costs$647$921$1,239
Value after costs$9,853$10,656$11,523
Impact on return, per year6.47%2.86%2.12%

EVIFX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 4%
  • Securities lending: none during the year

Eaton Vance Balanced Fund Share Classes

Net expense ratio and maximum front-end load of each share class, cheapest first.

TickerClassNet expense ratioFront load
ESIFXClass R60.67%none
EIIFXClass I0.71%none
EVIFXClass A0.96%5.25%
ERIFXClass R1.21%none
ECIFXClass C1.71%none

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.